GX-210 series

KinGen Biotech is set to manufacture various plasmid DNAs for Genexine Inc.’s development pipeline. The first set of plasmid DNAs is the GX-210 series, which is a cocktail of plasmid DNAs to be used in clinical trials in the treatment of late stage cervical cancer in Asia.